基于“肺肠相表里”理论探讨肠道菌群与肺病防治

Relationship Between Gut Microbiota and Lung Disease Prevention and Treatment Based on Theory of"Interaction between Lung and Large Intestine"

本文探讨了中医“肺与大肠相表里”理论在现代科学研究中的体现。该理论认为肺与大肠在生理和病理上紧密相连,并指出在治疗肺系疾病时可通过调节肠道实现。现代研究揭示了两者间微生物的相互作用,提出了基于肠道微生物的“肺-肠轴”概念,为中医理论提供了科学阐释。通过大量的文献研究揭示肠道菌群在肺系疾病发生、发展及中医药治疗中的变化规律,深入分析了肠道菌群、中药与肺系疾病之间的关联性和作用机制。本文旨在为肺系疾病的微生物治疗提供新思路,并为中药的现代化研究开辟新途径,以期更好地服务于人类健康。

This article explored the modern scientific applic ation of the"interaction between lung and large intestine" theory. This theory posits that the lungs and large intestine areintimately connected both physiologically and pathologically and suggests that by regulatingthe gut, pulmonary diseases can be treated. Modern research has unveiled the interactionbetween the microbiota of the two organs and introduced the concept of the "lung-gut axis"based on gut microbiota, thereby providing a scientific interpretation of traditional Chinesemedicine theories. Based on extensive literature research, the changes in gut microbiota duringthe occurrence, development, and treatment of pulmonary diseases by traditional Chinesemedicine were revealed, and the correlation and mechanism of action among gut microbiota,traditional Chinese medicine, and pulmonary diseases were analyzed. This article aims tooffer novel approaches for microbial therapy of pulmonary diseases and pioneer new paths forthe modernization of traditional Chinese medicine research, so as to better guarantee humanhealth.